Yu Lu, VP Business Operations at STA Pharmaceutical, a WuXi AppTec company, explains how the company has established its technological platforms for the oligos and peptides market and where it sees the field developing in the future.
This interview was filmed as part of TIDES TV at TIDES US in San Diego, CA, May 20-23, 2019.
Join us at TIDES Europe, Amsterdam, 12-15 November 2019: https://bit.ly/2IoyYP2
More info on Creating technologies for the peptides and oligonucleotides field – STA Pharmaceutical
NEUE THER : NEUBASE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Using its PATrOL™ platform, NeuBase can create antisense oligonucleotides ("ASO") that ... licensed exclusively from Carnegie Mellon University; technology to allow self-assembly of small gamma ...